Table 1 Representative immune-responsive lncRNAs regulated across multiple infections
Immune-responsive lncRNAs | Other disease/pathogenic infection | No. of pathogens DE in this study | References |
|---|---|---|---|
LINC01215 | LPS-induced inflammation, L.pneumophila infection | 11 | |
MAILR | LPS-induced inflammation, L.pneumophila infection | 10 | |
MIR155HG | HIV-1, Influenza A virus (IAV), hepatitis B virus (HBV), Epstein-Barr virus, multiple sclerosis (MS), Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), LPS-induced inflammation, Oral cancer | 10 | |
MIR222HG | Hepatitis C Virus (HCV), human immunodeficiency virus (HIV), prostrate cancer, breast cancer | 11 | |
MROCKI | MROCKI is induced by multiple Toll-like receptor (TLR) stimuli and acts as a master regulator of inflammatory responses | 7 | |
PACER | LPS-induced inflammation, Mycobacterium tuberculosis infection, pathogen-induced immune response, pancreatic ductal adenocarcinoma (PDAC), lung adenocarcinoma, tumor-associated macrophages in colon cancer, RA, pulmonary fibrosis, gastrointestinal cancer | 6 | |
LUCAT1 | Upregulation Promotes NF-κB-driven alarmin expression while suppressing JAK-STAT-mediated IFN responses; associated with severe COVID-19. | 5 | |
EGOT | Induced by cellular stress or PAMPs via PI3K/AKT, MAPK, and NF-κB pathways, promoting cell survival and inflammation; HPV infection | 4 |